RACHAEL ABELL: Open Payments
NPI 1992339345 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 13 payments from 9 companies in 2025. Trend: 2023 $317 · 2024 $406 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 1 | $44 |
| Corcept Therapeutics | 2 | $34 |
| ABBVIE INC. | 1 | $20 |
| Hologic Sales and Service, LLC | 1 | $20 |
| Amgen Inc. | 1 | $20 |
| Verona Pharma, Inc. | 1 | $19 |
| Viatris Specialty LLC | 1 | $15 |
Products named: Wegovy, XIFAXAN, FANAPT, Korlym, VRAYLAR, APTIMA, EVENITY, Ohtuvayre.
Industry payments across KY — which companies pay providers there.
